AbramowitzPwNoldEG.New directions for hospital pharmacy. Am J Hosp Pharm1984; 41: 724–6.
2.
AbramowitzPwNoldEgHatfieldSN.Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm1982; 39: 1176–80.
3.
PathakDsNoldEG.Cost-effectiveness of clinical pharmaceutical services; a follow-up report. Am J Hosp Pharm1979; 36: 1527–9.
4.
SchondelmeyerSW.Strategy to effect change in pharmacy practice. Am J Hosp Pharm1982; 39: 2137–42.
5.
GibsonJLIvancevichJmDonnellyJhJr.Organizations: behavior, structure, processes. Dallas, TX: Business Publications Inc, 1979.
6.
BrodieDC.Drug utilization and drug utilization review and control. DHEW publication No. (HSM) 72–3002. Rockville, MD: Dept. Health, Education, and Welfare, 1971.
7.
KnappDaKnappDeBrandonBM.Development and application of criteria in drug use review programs. Am J Hosp Pharm1974; 31: 648–56.
8.
HutchinsonRaWitteKW.How to get started—planning clinical pharmacy services. In: RayMD, ed. Basic skills in clinical pharmacy practice. Rockville, MD: American Society of Hospital Pharmacists, 1983: 20–45.
9.
StrandLmMorleyPC.Two approaches to cost containment in hospital pharmacy. Am J Hosp Pharm1985; 42: 852–6.
10.
PathakDsIntegrating strategic planning and marketing for hospital pharmacy directors. Top Hosp Pharm Manage1985; 5 (1): 8–24.
11.
BrodieDC.Pharmaceutical education in perspective. Am J Hosp Pharm1982; 39: 587–94.